Navigation Links
Eppendorf Video Features Dr Andrew Holt's Work on Bioactive Leachates From Plastic Consumables
Date:12/2/2011

HAMBURG, Germany, December 2, 2011 /PRNewswire/ --

Cross reference: Picture is available via epa european pressphoto agency and can be downloaded free of charge at: http://www.presseportal.de/pm/18701/eppendorf-ag?keygroup=bild

In a well-received report in Science from 2008, Dr. Andrew Holt and his group from the University of Alberta, Canada, described how chemicals used as manufacturing additives can substantially inhibit enzymatic assays and binding studies by leaching into samples from plastic consumables. Eppendorf recently visited Dr. Holt's pharmacology lab with a film crew to ask him how experimental data can be affected and what he recommends to other scientists to ensure unaffected and reproducible results.

Daniel Wehrhahn, product manager responsible for consumables at Eppendorf, commented: 'Dr. Holt's results clearly show that using pipette tips and microcentrifuge tubes from manufacturers that can confirm the absence of critical production additives leads to experimental results which are much more reliable and reproducible. Eppendorf high quality consumables are manufactured only from virgin polypropylene certified free of plasticizers, biocides or other unwanted additives which could leach into buffers and solvents, leading to false positive or false negative results in bioassays. Our material also complies with the FDA requirements for olefin polymers.'

Launched via the Eppendorf consumables web page, YouTube and social networking sites, the new video will quickly gain worldwide exposure, helping other researchers choose plastic consumables which are best suited to their assays. Scientific background information, recent publications and application data is also available on the website.  

Eppendorf's clean-room manufacturing processes are fully automated and subject to continuous quality monitoring. In addition, fully-automated production and special optimised molds that work without slip agents - such as Oleamide or DiHEMDA - ensure that epT.I.P.S. pipette tips®, Eppendorf Tubes® and Eppendorf Plates® satisfy the requirements of demanding applications. Batch-specific purity certificates can be downloaded from the Eppendorf website.

http://www.eppendorf.com/consumables

A Video interview with Dr. Andrew Holt is available at:

http://www.youtube.com/watch?v=LR1ljpp9TDE

 

Press contact:
Eppendorf AG
Bettina Doerler
public relations officer
doerler.b@eppendorf.de
+49-40-538-01-640



'/>"/>
SOURCE Eppendorf AG
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union
2. Eppendorf Licenses Technology for Thermal Cyclers to Bulldog Bio
3. Eppendorf AG Deploys a Strategic Information Management Solution on a Global Level
4. [video] Jacques Tizabi, CEO of Universal Detection Technology Discusses Latest Purchase Order on WallSt.nets 3-Minute Press Show
5. [video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.nets 3-Minute Press Show
6. Video: CSL Behring Provides $1.2M Grant for Worlds First Study of Postpartum Women with VWD, Common Bleeding Disorder
7. Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
8. Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School
9. Caliper Launches Small Animal Molecular Imaging System Enabling Real-Time Video Observation
10. Video: Keppra XR(TM) Approved in the U.S.
11. Video: Fortune 1000 Executives: New President Must Fix Education Gap
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... , Feb. 10, 2016 NX Prenatal Inc., ... proprietary NeXosome® technology for early warning of adverse ... most recent study by Dr. Thomas McElrath ... Society for Maternal Fetal Medicine,s (SMFM) annual meeting held ... th , 2016.  The presentation reported initial positive ...
(Date:2/10/2016)... RICHLAND, Wash., Feb. 10, 2016  IsoRay, Inc. (NYSE ... seed brachytherapy and medical radioisotope applications for the treatment ... cancers, today announced its financial results for the second ... December 31, 2015. --> ... second quarter of fiscal 2016, which ended December 31, ...
(Date:2/10/2016)... ... February 10, 2016 , ... Benchmark Research, a fully-integrated ... of two long-standing principal investigators (PI) to the roles of Chief Medical Officer, ... , Dr. Laurence Chu, a Benchmark Research PI in the Austin office, will ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... their comprehensive training and support program, Sonalinkā„¢ remote monitoring. The inaugural launch of ... on Friday, February 5th, connecting Dr. Samuel Peretsman to a HIFU technical expert ...
Breaking Biology Technology:
(Date:1/20/2016)... MINNETONKA, Minn. , Jan. 20, 2016   ... that supports the entire spectrum of clinical research, is ... in 2015. MedNet,s significant achievements are the result of ... of) iMedNet eClinical , it,s comprehensive, ... --> --> Key MedNet growth ...
(Date:1/15/2016)... , Jan. 15, 2016 Recent publicized breaches ... to find new ways to ensure data security and ... iOS and Android that ties a ... transforming it into a hardware authorization token. Customer service ... their fingerprint on their KodeKey enabled device to verify ...
(Date:1/11/2016)... Jan. 11, 2016 Synaptics Incorporated (NASDAQ: ... today announced that its ClearPad ® TouchView ™ ... won two separate categories in the 8 th ... Best Technology Breakthrough. The Synaptics ® TDDI solution ... supply chain, thinner devices, brighter displays and borderless designs. ...
Breaking Biology News(10 mins):